phenofAST

Antimicrobial Susceptibility Testing Solution

Health Tech & Life Sciences
Active
Seed Haifa, Israel Founded 2018
Last updated 2026-06-18
Total raised
Last: 2021-04
Stage
Seed
Founded
2018
Headcount
4
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

phenofAST has developed a fast and affordable clinical diagnostic solution for antibiotic susceptibility testing, providing definitive test results within 4 hours from a positive culture. Antibiotic susceptibility tests (AST) can take 2 to 3 days to produce definitive results, and with the accelerated spread of antibiotic-resistant bacteria, inappropriate antibiotic treatment results in mortality, morbidity, and higher healthcare costs across all stakeholders.

phenofAST is the only company to have completely new & innovative physics-based technology, detecting cell division through laser light interferences, powered by AI analysis. phenofASTs solution provides same day AST test results in a cost effective way for a wide range of indications. This solution is applicable to any microbiology lab due to it's modular design – fit any lab space and needs, Green, minimal waste operation and low price of disposable testing cassette. With phenofAST solution, the microbiology lab will be able to provide the physician with the AST results, enabling the physician to adjust the antibiotic treatment on the same day that the patient was admitted, minimizing AMR ( antimicrobial resistance) and maximizing the right and effective treatment needed.

Clinical validations done so far provided very high agreement with the gold standard. phenofAST goal is to become the Standard of Practice in antibiotic susceptibility testing, proving fast, cost-effective and wide-range solution for healthcare providers and payers.

Funding history · 1 round · — total

2021-04
Undisclosed

Q&A

What is phenofAST's primary focus?
phenofAST develops a fast and affordable clinical diagnostic solution for antibiotic susceptibility testing, aiming to provide definitive results within 4 hours from a positive culture.
When was phenofAST founded?
phenofAST was founded in February 2018.
What technology does phenofAST utilize for its diagnostic solution?
phenofAST uses a physics-based technology that detects cell division through laser light interferences, powered by AI analysis.
Which investor participated in phenofAST's funding round in April 2021?
MindUP participated in phenofAST's funding round in April 2021.
What is the primary sector of phenofAST?
phenofAST's primary sector is Health Tech & Life Sciences.
What is phenofAST's current product stage?
phenofAST's product is currently in beta stage.
Does phenofAST hold any patents?
Yes, phenofAST holds 1 patent.

Team · 2

Founder · Founder & CTO
LinkedIn ↗
Founder · Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
Artificial IntelligenceImage RecognitionSensingLaserOpticPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersLaboratoriesPatientsMedical Devices IndustryMedical EquipmentLife SciencesBiotechnology
Business model
B2B

Highlights

1 PatentsVerified

Tags

real-timeopticsartificial-intelligencelaserssensorshealthcare-providerslaboratoriespharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitephenofast.com/
LinkedInlinkedin.com/company/71559460/

Identifiers & details

Former namesTishrei Diagnostics
Founded2018-2
Employees (exact)4

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainphenofast.com